Over the past years, our clinical focus has remained consistent: identify root causes, intervene early, and apply therapies that are both evidence-informed and outcome-driven. Medicine evolves, and so must we.
The new protocol has been developed in response to emerging data, patient outcomes, and the growing understanding of chronic inflammation, immune dysregulation, vascular stress, and toxin burden as core drivers of long-term health decline. This protocol is not an add-on. It is a strategic refinement of how we assess, prioritize, and treat systemic dysfunction.
What makes this protocol different is integration. Advanced diagnostics are directly linked to targeted interventions. Biomarkers guide therapy selection. Treatment sequencing is intentional. Monitoring is structured. The objective is measurable improvement, not theoretical optimization.
For patients already committed to proactive longevity care, this represents the next level of precision. For those managing complex or persistent symptoms, it provides a more structured pathway to clarity and progress.
Our responsibility is not only to treat, but to anticipate. This protocol reflects our commitment to staying ahead of emerging risks, applying rigorous clinical reasoning, and maintaining the highest standards of individualized care.
We encourage you to review the full protocol details and discuss with our team whether this approach aligns with your current health strategy.
Thank you for letting us be part of your healing. It is a privilege we cherish and thank you for teaching us daily about what resilience truly looks like.
Your Next Step
If you have already completed your initial treatment plan, you can discuss eligibility and alignment with your current health strategy during a free consultation:
→ https://api.leadconnectorhq.com/widget/bookings/consultation-markus-klotz
Your health trajectory deserves deliberate design.
With respect and warmth,
Dr Inbar Almon Tofan
Apheresis Medical Director
